| Net Cash Provided by (Used in) Operating Activities |
$822,781 |
USD |
4.1% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$314,678 |
USD |
-69% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
300,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
11,431,926 |
shares |
51% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$510,038 |
USD |
-283% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$1,106,489 |
USD |
208% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$573,529 |
USD |
-48% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$11,561,535 |
USD |
-11% |
Q4 2024 |
FY 2024 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Gross |
$11,561,535 |
USD |
-11% |
Q4 2024 |
FY 2024 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$2,538,699 |
USD |
-86% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$10,663,939 |
USD |
-3.8% |
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$8,400,000 |
USD |
|
Q4 2024 |
FY 2024 |
| Amortization of Intangible Assets |
$33,333 |
USD |
0% |
Q1 2025 |
Q1 2025 |
| Depreciation, Depletion and Amortization |
$33,333 |
USD |
-0% |
Q1 2025 |
Q1 2025 |
| Share-based Payment Arrangement, Expense |
$19,941 |
USD |
0% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$369,992 |
USD |
-11% |
Q1 2025 |
Q1 2025 |